Plasma therapies are one of the treatments that have become fashionable in the United States, which can cost between eight thousand and 12 thousand dollars.
Last Tuesday, Food and Drug Administration (FDA) warned about the risks caused by these treatments.
Plasma is a part of the blood fluid that includes the factors that allow it to sleep, antibodies and other proteins, but not white or red cells.
The "therapy" is practiced as a normal intravenous transfusion, where the patient receives the plasma from a donor, usually younger, under the belief that he can benefit from a lot rich.
Before administering the plasma in the receptor, the blood goes through a disinfection process that includes centrifugation and different temperature changes to separate the plasma components of the rest of the blood.
Picture: "Therapy" is practiced as a normal intravenous transfusion, where the patient receives the plasma by a donor, usually younger. (Getty Images)
These therapies are published to treat diseases such as Alzheimer's, Parkinson's, multiple sclerosis, post-traumatic stress and memory loss, but the FDA has warned in its statement that there is no evidence to support it effectiveness.
"The FDA does not approve Plasma to treat conditions such as normal aging or memory loss. In addition, reliable studies have not shown the clinical benefit of young donor plasma administration and there are associated security risks."
And, the agency says that if there are some benefits, they are much lower than the risks involved. Amongst the most outstanding quotes:
Infections: the administered plasma dosage is high and although it is analyzed to detect infectious agents, there are still bacterial transmission risks.
Allergies: Plasma transfers are often associated with severe allergic reactions such as anaphylaxis, which can cause cattle and block and respiratory tract.
Respiratory problems: Sometimes plasma conveyances can cause severe lung injury.
Cardiovascular complications: Sometimes, transfusion can cause overloading of the circulation system, causing the body to be swell and breathe difficult. People with existing heart disease are more likely to experience complications.
Finally, the agency explains that these plasma treatments have been designed for patients with very specific conditions that go to centers that comply with Food and Drug Administration regulations & # 39; r United States and are supervised by a doctor.
Each one represents a risk, they come to the conclusion.
Plasma treatments have been in fashion in the United States for a few years, and since 2015 they have begun to appear in Latin America, where the most commonly used treatment is Plasma Rich Platelet (PRP), which includes self – translate your own plasma that is treated and removed from infectious agents.
Three years ago, the Association of Hemotherapy and Immunoematicism launched a warning on the risks of infection caused by this type of therapy.
With BBC information.